-
Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11
Tuesday, February 23, 2021 - 11:33am | 246Health Canada has approved Sanofi’s SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) DUPIXENT (dupilumab injection) for the treatment of moderate-to-severe atopic dermatitis in children aged six to 11 years whose disease is not adequately...
-
Ultragenyx's Dojolvi Ok'd In Canada For Genetic Metabolic Disorder
Wednesday, February 17, 2021 - 10:44am | 206Health Canada approves Ultragenyx Pharmaceutical Inc's (NASDAQ: RARE) Dojolvi (triheptanoin) as a source of calories and fatty acids for the treatment of adult and pediatric patients with long-chain fatty acid oxidation disorders (LC-FAOD). LC-FAOD are a group of rare, genetic,...
-
Psyched: MDMA On Health Canada's Radar, MindMed Seeks FDA Support For LSD, Numinus Buys Mindspace
Saturday, December 19, 2020 - 9:30am | 987Health Canada Considers MDMA And Psilocybin 'Special Access' Program This week, Health Canada opened a public consultation on its “proposal to restore potential access to restricted drugs through the Special Access Program (SAP).” The SAP allows healthcare professionals to...
-
Psyched: Cybin Raises CA$45M, Numinus Harvests Legal Mushrooms, Toadstool Enters Psychedelic Space
Sunday, October 25, 2020 - 8:23am | 976Cybin Raises CA$45 Million and Heads Towards NEO Exchange This week, Toronto-based Cybin Corp. announced the closing of a private offering for CA$45 million ($34.2 million). The raise was completed in connection to Cybin’s previously-announced reverse take-over with Clarmin Explorations (TSXV...
-
Canadian Biotech IMV 'Rapidly' Progressing On Coronavirus Vaccine Development
Tuesday, July 14, 2020 - 10:07am | 306Imv Inc (NASDAQ: IMV) share are ripping higher on above-average volume following an update by the company on its coronavirus vaccine program. What Happened? The Dartmouth, Nova Scotia-based company said it's rapidly progressing in developing DPX-COVID-19, its vaccine candidate against SARS-...
-
Thrive Cannabis Rolls Out Greybeard's Products For July 2020
Tuesday, June 30, 2020 - 12:24pm | 286Thrive Cannabis has launched a line of premium small-batch products under its flagship recreational brand - Greybeard Cannabis Co. The Simcoe, Ontario-based manufacturer of craft cannabis concentrates and dried flower expects its first batch of Greybeard products to be available across Ontario...
-
Rubicon Organics To Obtain Medical Cannabis Sales License, Expand Capacities
Wednesday, May 6, 2020 - 1:28pm | 284Canadian cannabis producer Rubicon Organics (OTCQX: ROMJF) announced Wednesday it has obtained a medical sales license to sell its products directly to customers. The Vancouver-based company has earned Health Canada’s approval for expansion of its indoor and outdoor...
-
North Bud's Quebec Facility Obtains Health Canada's Cultivation License
Monday, March 16, 2020 - 1:56pm | 336North Bud Farms Inc. (OTC: NOBDF)(CSE: NBUD) has obtained Health Canada’s standard cultivation license for a 24,500 square-foot indoor cannabis cultivation space in Quebec. The company said Monday this license enables its subsidiary, GrowPros MMP Inc., to begin indoor...
-
Canntab Obtains Health Canada Cannabis Research License
Monday, February 24, 2020 - 11:17am | 247Canntab Therapeutics Limited (OTC: CTABF)(CSE: PILL.CN), a Canadian company known for its solid oral dose formulations of cannabis with a line of cannabinoid and terpenoid blends, said Monday it has obtained Health Canada cannabis research license for operations at its Markham Ontario Facility....
-
Sproutly Subsidiary Obtains Canadian Flower Sales License In Q3
Thursday, January 30, 2020 - 10:49am | 385Sproutly Canada, Inc. (CSE: SPR) (OTC: SRUTF) reported third-quarter financial results and operational highlights Wednesday. Sproutly's wholly owned licensed cannabis producer Toronto Herbal Remedies obtained a Health Canada sales license for cannabis flower, according to the company. The...
-
Dermatology Company Obtains Cannabis Research License
Friday, January 24, 2020 - 12:41pm | 278Commercial dermatology company Crescita Therapeutics Inc. (TSX: CTX) (OTC: CRRTF) said Friday its subsidiary INTEGA Skin Sciences Inc. has obtained a cannabis research license by Health Canada. The license enables the company to have cannabis for research and development purposes. INTEGA’s...
-
Over 750 Zenabis CBD Gelcaps Recalled By Health Canada
Wednesday, December 18, 2019 - 11:36am | 240Health Canada recalled 768 units of Zenabis Global Inc (TSE: ZENA) (OTC: ZBISF) Namaste CBD Light gelcaps Tuesday after it was discovered the products contain higher-than-labeled levels of THC and no CBD. Zenabis previously had its Namaste Wappa dried cannabis pulled from shelves in...
-
Organigram Receives Health Canada Licenses For Chocolate Production
Friday, December 13, 2019 - 11:33am | 334Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) said Friday that it has obtained Health Canada approval for 16 additional cultivation rooms. With the newly licensed cultivation rooms, Organiram’s Moncton campus will reach 89,000 kg of licensed capacity in year one and the...
-
True Leaf Secures 3 Health Canada Licenses To Cultivate, Process, Sell Medical Marijuana
Monday, November 25, 2019 - 11:28am | 303True Leaf Brands Inc (CSE:MJ) (OTC: TRLFF) subsidiary True Leaf Cannabis Inc. said Monday it has secured Health Canada’s licenses for cultivation, processing and selling cannabis for medical purposes for its True Leaf Campus facility. The license enables True Leaf to commence with the...
-
Canada's New Health Minister's Thoughts On Cannabis: What You Should Know
Monday, November 25, 2019 - 10:23am | 527Canadian Prime Minister Justin Trudeau has unveiled the list of ministers who will make up his cabinet for his second term. Patty Hajdu, formerly the minister of employment, will replace Ginette Petitpas Taylor as minister of health. Canada’s Minister of Health holds special...